Latest News about ABCL
Recent news which mentions ABCL
AbCellera, Everest Medicines Team Up To Develop 10 Therapeutic Antibodies
September 23, 2021
Tickers
ABCL
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
Cramer's Advice On Ulta Beauty, Laredo Petroleum And More
September 23, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 17, 2021
From InvestorPlace
15 Stocks Moving in Friday's Pre-Market Session
September 17, 2021
From Benzinga
AbCellera Stock Is Moving Higher After Expanded Use Nod For Lilly-Partnered COVID-19 Antibody
September 17, 2021
From Benzinga
Why AbCellera Biologics Stock Jumped 7% on Wednesday
September 15, 2021
From Motley Fool
AbCellera Shares Are Moving Higher On Licensing Pact With Moderna
September 15, 2021
From Benzinga
Here's Why AbCellera Biologics Stock Gained 10.6% Last Month
September 04, 2021
From Motley Fool
78 Biggest Movers From Friday
August 16, 2021
From Benzinga
Why AbCellera Biologics Stock Was Up More Than 17% on Friday
August 13, 2021
From Motley Fool
53 Stocks Moving In Friday's Mid-Day Session
August 13, 2021
From Benzinga
AbCellera Biologics Inc. (ABCL) Q2 2021 Earnings Call Transcript
August 13, 2021
Tickers
ABCL
From Motley Fool
From Motley Fool
From Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 20, 2021
From Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
July 16, 2021
From Benzinga
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
July 15, 2021
From Benzinga
From Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
July 14, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
